Neuroimmunological therapies for treating spinal cord injury: Evidence and future perspectives
- PMID: 33745920
- DOI: 10.1016/j.expneurol.2021.113704
Neuroimmunological therapies for treating spinal cord injury: Evidence and future perspectives
Abstract
Spinal cord injury (SCI) has a complex pathophysiology. Following the initial physical trauma to the spinal cord, which may cause vascular disruption, hemorrhage, mechanical injury to neural structures and necrosis, a series of biomolecular cascades is triggered to evoke secondary injury. Neuroinflammation plays a major role in the secondary injury after traumatic SCI. To date, the administration of systemic immunosuppressive medications, in particular methylprednisolone sodium succinate, has been the primary pharmacological treatment. This medication is given as a complement to surgical decompression of the spinal cord and maintenance of spinal cord perfusion through hemodynamic augmentation. However, the impact of neuroinflammation is complex with harmful and beneficial effects. The use of systemic immunosuppressants is further complicated by the natural onset of post-injury immunosuppression, which many patients with SCI develop. It has been hypothesized that immunomodulation to attenuate detrimental aspects of neuroinflammation after SCI, while avoiding systemic immunosuppression, may be a superior approach. To accomplish this, a detailed understanding of neuroinflammation and the systemic immune responses after SCI is required. Our review will strive to achieve this goal by first giving an overview of SCI from a clinical and basic science context. The role that neuroinflammation plays in the pathophysiology of SCI will be discussed. Next, the positive and negative attributes of the innate and adaptive immune systems in neuroinflammation after SCI will be described. With this background established, the currently existing immunosuppressive and immunomodulatory therapies for treating SCI will be explored. We will conclude with a summary of topics that can be explored by neuroimmunology research. These concepts will be complemented by points to be considered by neuroscientists developing therapies for SCI and other injuries to the central nervous system.
Keywords: Adaptive immune response; Blood-spinal cord-barrier; Immune organs; Immunomodulation; Immunosuppression; Innate immune response; Neuroimmunology; Neuroinflammation; Spinal cord injury.
Copyright © 2021 Elsevier Inc. All rights reserved.
Similar articles
-
Delayed administration of high dose human immunoglobulin G enhances recovery after traumatic cervical spinal cord injury by modulation of neuroinflammation and protection of the blood spinal cord barrier.Neurobiol Dis. 2021 Jan;148:105187. doi: 10.1016/j.nbd.2020.105187. Epub 2020 Nov 26. Neurobiol Dis. 2021. PMID: 33249350
-
Treatment of spinal cord injury with intravenous immunoglobulin G: preliminary evidence and future perspectives.J Clin Immunol. 2014 Jul;34 Suppl 1(Suppl 1):S132-8. doi: 10.1007/s10875-014-0021-8. Epub 2014 Apr 11. J Clin Immunol. 2014. PMID: 24722853 Free PMC article. Review.
-
Neuregulin-1 elicits a regulatory immune response following traumatic spinal cord injury.J Neuroinflammation. 2018 Feb 21;15(1):53. doi: 10.1186/s12974-018-1093-9. J Neuroinflammation. 2018. PMID: 29467001 Free PMC article.
-
The paradox of chronic neuroinflammation, systemic immune suppression, autoimmunity after traumatic chronic spinal cord injury.Exp Neurol. 2014 Aug;258:121-129. doi: 10.1016/j.expneurol.2014.04.023. Exp Neurol. 2014. PMID: 25017893 Free PMC article. Review.
-
Non-mammalian model systems for studying neuro-immune interactions after spinal cord injury.Exp Neurol. 2014 Aug;258:130-40. doi: 10.1016/j.expneurol.2013.12.023. Exp Neurol. 2014. PMID: 25017894 Free PMC article. Review.
Cited by
-
Oscillating field stimulation promotes neurogenesis of neural stem cells through miR-124/Tal1 axis to repair spinal cord injury in rats.Neural Regen Res. 2023 Apr;18(4):895-900. doi: 10.4103/1673-5374.353505. Neural Regen Res. 2023. PMID: 36204860 Free PMC article.
-
Regulatory Role of Mesenchymal Stem Cells on Secondary Inflammation in Spinal Cord Injury.J Inflamm Res. 2022 Jan 26;15:573-593. doi: 10.2147/JIR.S349572. eCollection 2022. J Inflamm Res. 2022. PMID: 35115806 Free PMC article. Review.
-
Ferroptosis inhibitor improves outcome after early and delayed treatment in mild spinal cord injury.Acta Neuropathol. 2024 Jun 22;147(1):106. doi: 10.1007/s00401-024-02758-2. Acta Neuropathol. 2024. PMID: 38907771 Free PMC article.
-
Mesenchymal Stem Cell Transplantation: Neuroprotection and Nerve Regeneration After Spinal Cord Injury.J Inflamm Res. 2023 Oct 20;16:4763-4776. doi: 10.2147/JIR.S428425. eCollection 2023. J Inflamm Res. 2023. PMID: 37881652 Free PMC article. Review.
-
Plasticity of colonic enteric nervous system following spinal cord injury in male and female rats.Neurogastroenterol Motil. 2023 Nov;35(11):e14646. doi: 10.1111/nmo.14646. Epub 2023 Jul 21. Neurogastroenterol Motil. 2023. PMID: 37480186 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical